{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T20:42:17Z","timestamp":1776285737265,"version":"3.50.1"},"reference-count":24,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>Fetal growth restriction (FGR) is a disorder defined as the failure of a fetus to achieve its full biological development potential due to decreased placental function, which can be attributed to a range of reasons. FGR is linked to negative health outcomes during the perinatal period, including increased morbidity and mortality. Long-term health problems, such as impaired neurological and cognitive development, as well as cardiovascular and endocrine diseases, have also been found in adulthood. Aspirin administered prophylactically to high-risk women can effectively prevent FGR. FGR pregnancy care comprises several steps, including the weekly assessment of several blood vessels using Doppler measurements, amniotic fluid index (AFI), estimated fetal weight (EFW), cardiotocography (CTG), as well as delivery by 37 weeks. Pregnancy is a complex condition characterized by metabolic adjustments that guarantee a consistent provision of vital metabolites allowing the fetus to grow and develop. The lipoprotein lipid physiology during pregnancy has significant consequences for both the fetus and baby, and for the mother. In the course of a typical pregnancy, cholesterol levels increase by roughly 50%, LDL-C (low-density lipoprotein cholesterol) levels by 30\u201340%, HDL-C by 25% (high-density lipoprotein cholesterol). Typically, there is also a 2- to 3-fold increase in triglycerides. Low maternal blood cholesterol levels during pregnancy are linked to a decrease in birth weight and an increased occurrence of microcephaly. FGR impacts the placenta during pregnancy, resulting in alterations in lipid metabolism. Research has been undertaken to distinguish variations in protein expression between normal placentas and those impacted by FGR. This can aid in comprehending the fundamental pathogenic mechanisms of FGR and perhaps pave the way for the creation of novel diagnostic and treatment methods. Commonly employed approaches for detecting and analyzing variations in placental proteomes include mass spectrometry, bioinformatic analysis, and various proteomic techniques.<\/jats:p>","DOI":"10.3390\/metabo14110632","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T10:44:37Z","timestamp":1732013077000},"page":"632","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Introduction to the Proteomic Analysis of Placentas with Fetal Growth Restriction and Impaired Lipid Metabolism"],"prefix":"10.3390","volume":"14","author":[{"given":"Malwina","family":"Sypia\u0144ska","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Pathology of Pregnancy, Medical University of Lublin, Clinical University Hospital n1, Staszica 16, 20-081 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8784-510X","authenticated-orcid":false,"given":"Aleksandra","family":"Stupak","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Pathology of Pregnancy, Medical University of Lublin, Clinical University Hospital n1, Staszica 16, 20-081 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/uog.15884","article-title":"Consensus definition of fetal growth restriction: A Delphi procedure","volume":"48","author":"Gordijn","year":"2016","journal-title":"Ultrasound Obstet. Gynecol. Off. J. Int. Soc. Ultrasound Obstet. Gynecol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/uog.20854","article-title":"Validation of Delphi procedure consensus criteria for defining fetal growth restriction","volume":"56","author":"Molina","year":"2020","journal-title":"Ultrasound Obstet. Gynecol. Off. J. Int. Soc. Ultrasound Obstet. Gynecol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"King, V.J., Bennet, L., Stone, P.R., Clark, A., Gunn, A.J., and Dhillon, S.K. (2022). Fetal growth restriction and stillbirth: Biomarkers for identifying at risk fetuses. Front. Physiol., 13.","DOI":"10.3389\/fphys.2022.959750"},{"key":"ref_4","first-page":"645","article-title":"Factors associated with fetal growth restriction and small for gestational age newborns","volume":"94","author":"Milosavljevic","year":"2022","journal-title":"Ginekol. Pol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"634","DOI":"10.5603\/GP.2020.0158","article-title":"Polish Society of Gynecologist and Obstetricians Recommendations on diagnosis and management of fetal growth restriction","volume":"91","author":"Kwiatkowski","year":"2020","journal-title":"Ginekol. Pol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5005\/jp-journals-10016-1294","article-title":"Stage-based FGR (Barcelona Protocol): Perinatal Outcome in SGA and FGR","volume":"13","author":"Kachakayala","year":"2022","journal-title":"Int. J. Infertil. Fetal Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: Systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000459633","article-title":"Metabolic Adaptations in Pregnancy: A Review","volume":"70","author":"Zeng","year":"2017","journal-title":"Ann. Nutr. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1385\/ENDO:19:1:43","article-title":"Lipid metabolism in pregnancy and its consequences in the fetus and newborn","volume":"19","author":"Herrera","year":"2002","journal-title":"Endocrine"},{"key":"ref_10","unstructured":"Wild, R., and Feingold, K.R. (2023). Effect of Pregnancy on Lipid Metabolism and Lipoprotein Levels. Endotext [Internet], South Dartmouth."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jprot.2016.04.027","article-title":"Proteoform profiling of peripheral blood serum proteins from pregnant women provides a molecular IUGR signature","volume":"149","author":"Koy","year":"2016","journal-title":"J. Proteom."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3109\/10641955.2010.544805","article-title":"The evaluation of the oxidative state of low-density lipoproteins in intrauterine growth restriction and preeclampsia","volume":"31","author":"Pecks","year":"2012","journal-title":"Hypertens. Pregnancy"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.preghy.2016.04.003","article-title":"A study of serum Apo A-1 and Apo B-100 levels in women with preeclampsia","volume":"6","author":"Timur","year":"2016","journal-title":"Pregnancy Hypertens."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"LaBarre, J.L., Puttabyatappa, M., Song, P.X.K., Goodrich, J.M., Zhou, L., Rajendiran, T.M., Soni, T., Domino, S.E., Treadwell, M.C., and Dolinoy, D.C. (2020). Maternal lipid levels across pregnancy impact the umbilical cord blood lipidome and infant birth weight. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-71081-z"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Miranda, J., Sim\u00f5es, R.V., Paules, C., Ca\u00f1ueto, D., Pardo-Cea, M.A., Garc\u00eda-Mart\u00edn, M.L., Crovetto, F., Fuertes-Martin, R., Domenech, M., and G\u00f3mez-Roig, M.D. (2018). Metabolic profiling and targeted lipidomics reveals a disturbed lipid profile in mothers and fetuses with intrauterine growth restriction. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-31832-5"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"596","DOI":"10.18203\/2349-3291.ijcp20200685","article-title":"Third trimester maternal blood and at birth cord blood lipid profile characteristics in pregnant woman with or without fetal growth restriction","volume":"7","author":"Nayan","year":"2020","journal-title":"Int. J. Contemp. Pediatr."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Alahakoon, T.I., Medbury, H.J., Williams, H., and Lee, V.W. (2020). Lipid profiling in maternal and fetal circulations in preeclampsia and fetal growth restriction-a prospective case control observational study. BMC Pregnancy Childbirth, 20.","DOI":"10.1186\/s12884-020-2753-1"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Gootjes, D.V., Posthumus, A.G., Wols, D.F., de Rijke, Y.B., Roeters Van Lennep, J.E., and Steegers EA, P. (2022). Maternal lipid profile in pregnancy and embryonic size: A population-based prospective cohort study. BMC Pregnancy Childbirth, 22.","DOI":"10.1186\/s12884-022-04647-6"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S2213-8587(22)00250-9","article-title":"Fetal growth patterns as early markers of fetal programming","volume":"10","author":"Figueras","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Miturski, A., G\u0119ca, T., Stupak, A., Kwa\u015bniewski, W., and Semczuk-Sikora, A. (2023). Influence of Pre-Pregnancy Obesity on Carbohydrate and Lipid Metabolism with Selected Adipokines in the Maternal and Fetal Compartment. Nutrients, 15.","DOI":"10.3390\/nu15092130"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1159\/000366371","article-title":"Comparative proteomic profile of the human placenta in normal and fetal growth restriction subjects","volume":"34","author":"Miao","year":"2014","journal-title":"Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Starodubtseva, N.L., Tokareva, A.O., Volochaeva, M.V., Kononikhin, A.S., Brzhozovskiy, A.G., Bugrova, A.E., Timofeeva, A.V., Kukaev, E.N., Tyutyunnik, V.L., and Kan, N.E. (2023). Quantitative Proteomics of Maternal Blood Plasma in Isolated Intrauterine Growth Restriction. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242316832"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Paules, C., Youssef, L., Miranda, J., Crovetto, F., Estanyol, J.M., Fernandez, G., Crispi, F., and Gratac\u00f3s, E. (2020). Maternal proteomic profiling reveals alterations in lipid metabolism in late-onset fetal growth restriction. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-78207-3"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3892\/mmr.2022.12872","article-title":"Placental proteome in late-onset of fetal growth restriction","volume":"26","author":"Stupak","year":"2022","journal-title":"Mol. Med. Rep."}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/14\/11\/632\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:33:43Z","timestamp":1760114023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/14\/11\/632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,16]]},"references-count":24,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["metabo14110632"],"URL":"https:\/\/doi.org\/10.3390\/metabo14110632","relation":{},"ISSN":["2218-1989"],"issn-type":[{"value":"2218-1989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,16]]}}}